Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
AKRX > SEC Filings for AKRX > Form 8-K on 25-Oct-2012All Recent SEC Filings

Show all filings for AKORN INC

Form 8-K for AKORN INC


Other Events

Item 8.01 Other Events.

On October 24, 2012, the Akorn, Inc. (the "Company") issued a press release announcing that its development and manufacturing partner, Sofgen Pharmaceuticals, LLC, ("Sofgen") received approval from the U.S. Food and Drug Administration ("FDA") for its abbreviated new drug application for Progesterone capsules, 100mg and 200mg, and that the Company, which has exclusive marketing rights in the U.S., has begun distribution of the product. Progesterone capsules are the generic of Abbott Laboratories' Prometrium® capsules, which are indicated for the treatment of endometrial hyperplasia and secondary amenorrhea.

  Add AKRX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for AKRX - All Recent SEC Filings
Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.